HighTower Advisors’s Asensus Surgical, Inc. ASXC Stock Holding History

HighTower Advisors’s Portfolio ASXC Stock Details ASXC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-1,335	Closed	-$12K	–	2560
2019 Q3	$12K	Hold	1,335	–	–	﹤0.01%	2301
2019 Q2	$24K	Buy	1,335 +332	+33%	+$7.27K	﹤0.01%	2255
2019 Q1	$30K	Sell	1,003 -589	-37%	-$19.7K	﹤0.01%	2157
2018 Q4	$46K	Sell	1,592 -310	-16%	-$14.1K	﹤0.01%	2039
2018 Q3	$143K	Sell	1,902 -95	-5%	-$6.43K	﹤0.01%	2008
2018 Q2	$113K	Sell	1,997 -724	-27%	-$26.4K	﹤0.01%	1991
2018 Q1	$61K	Sell	2,721 -4,077	-60%	-$93.3K	﹤0.01%	2008
2017 Q4	$171K	Buy	+6,798	New	+$209K	﹤0.01%	1953

Other funds holding ASXC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

SHI

SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

MCM

Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

HighTower Advisors's ASXC Position: Q4 2019 in Review

HighTower Advisors sold out of Asensus Surgical, Inc. (ASXC) in Q4 2019, closing a stake of 1,335 shares — an estimated $12K sold.

HighTower Advisors first reported a position in ASXC in Q4 2017 and held it in 8 quarters. The position peaked at $171K in Q4 2017. 81 funds tracked by Wall St. Rank hold ASXC as of Q4 2019.

HighTower Advisors reported no remaining Asensus Surgical, Inc. position as of Q4 2019 after selling out during the quarter.
HighTower Advisors sold 1,335 Asensus Surgical, Inc. shares in Q4 2019, an estimated $12K.
HighTower Advisors first reported a position in Asensus Surgical, Inc. in Q4 2017 and held it in 8 quarters.
HighTower Advisors's Asensus Surgical, Inc. position peaked at $171K in Q4 2017.
81 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q4 2019.

Based on HighTower Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.